S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples